Castle Biosciences (CSTL) Change in Acquisitions & Divestments (2023 - 2026)

Castle Biosciences (CSTL) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $2.7 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 92.61% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $155.6 million (up 1219.29% YoY) and the FY2025 annual result came in at $189.2 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments eased to $2.7 million in Q1 2026 per CSTL's latest filing, from $54.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $54.9 million in Q3 2025, with the low at -$123.2 million in Q4 2024.
• Average Change in Acquisitions & Divestments over 4 years is $29.1 million, with a median of $44.0 million recorded in 2025.
• Year-over-year, Change in Acquisitions & Divestments plunged 354.12% in 2024 and soared 143.81% in 2025.
• Castle Biosciences' Change in Acquisitions & Divestments stood at $48.5 million in 2023, then sank by 354.12% to -$123.2 million in 2024, then surged by 143.81% to $54.0 million in 2025, then sank by 95.04% to $2.7 million in 2026.
• Business Quant data shows CSTL's Change in Acquisitions & Divestments at $2.7 million in Q1 2026, $54.0 million in Q4 2025, and $54.9 million in Q3 2025.